Journal
BMC MICROBIOLOGY
Volume 17, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/s12866-017-1133-0
Keywords
Microbiome; Antibiotic susceptibility; Phytochemicals; Metabolites
Categories
Funding
- BBSRC-CASE studentship from BBSRC
- Inspiralis Ltd.
- Plant Bioscience Ltd.
- BBSRC (UK) [BB/J004561/1]
- John Innes Foundation
- Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201, 1208873, BBS/E/J/000PR9791] Funding Source: researchfish
- BBSRC [BBS/E/J/000PR9791] Funding Source: UKRI
Ask authors/readers for more resources
Background: Although plants produce many secondary metabolites, currently none of these are commercial antibiotics. Insects feeding on specific plants can harbour bacterial strains resistant to known antibiotics suggesting that compounds in the plant have stimulated resistance development. We sought to determine whether the occurrence of antibiotic-resistant bacteria in insect guts was a widespread phenomenon, and whether this could be used as a part of a strategy to identify antibacterial compounds from plants. Results: Six insect/plant pairs were selected and the insect gut bacteria were identified and assessed for antibiotic susceptibilities compared with type strains from culture collections. We found that the gut strains could be more or less susceptible to antibiotics than the type strains, or show no differences. Evidence of antibacterial activity was found in the plant extracts from five of the six plants, and, in one case Catharanthus roseus (Madagascar Periwinkle), compounds with antibacterial activity were identified. Conclusion: Bacterial strains isolated from insect guts show a range of susceptibilities to antibiotics suggesting a complex interplay between species in the insect gut microbiome. Extracts from selected plants can show antibacterial activity but it is not easy to isolate and identify the active components. We found that vindoline, present in Madagascar Periwinkle extracts, possessed moderate antibacterial activity. We suggest that plant-derived antibiotics are a realistic possibility given the advances in genomic and metabolomic methodologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available